In laboratory experiments with bone marrow stem cells from children with aplastic anemia, thymosin alpha-1 reduced the abnormal expression of an inflammatory receptor (TLR9) and activated an immune-regulating enzyme (IDO). These effects occurred in a dose- and time-dependent manner, suggesting a potential mechanism by which the peptide could help restore immune balance in this blood disorder.
Hou, Fang; Huang, Jian-Ming; Li, Ge